|
Animal Husbandry Technician
|
Cambridge, MA, US, 02142
|
May 26, 2026
|
Full-Time
|
|
|
Scientist, mRNA
|
Cambridge, MA, US, 02142
|
May 26, 2026
|
Full-Time
|
|
|
Associate Director, Field Systems and Technology
|
Cambridge, MA, US, 02142
|
May 23, 2026
|
Full-Time
|
|
|
Senior Associate Scientist, Ligand Discovery
|
Cambridge, MA, US, 02142
|
May 27, 2026
|
Full-Time
|
|
|
Vice President, Global Trial Optimization
|
Cambridge, MA, US, 02142
|
May 16, 2026
|
Full-Time
|
|
|
Director, New Product Planning & BD Support
|
Cambridge, MA, US, 02142
|
May 15, 2026
|
Full-Time
|
|
|
Director, Cyber Architecture & Engineering
|
Cambridge, MA, US, 02142
|
May 22, 2026
|
Full-Time
|
|
|
Sr. Manager, Regulatory Affairs, CMC
|
Cambridge, MA, US, 02142
|
May 22, 2026
|
Full-Time
|
|
|
Senior Medical Director, Clinical Research- Hepatology
|
Cambridge, MA, US, 02142
|
May 23, 2026
|
Full-Time
|
|
|
Senior Medical Director, Clinical Research - Neurodegeneration
|
Cambridge, MA, US, 02142
|
May 23, 2026
|
Full-Time
|
|
|
Executive Director, Global Trial Strategy & Operations
|
Cambridge, MA, US, 02142
|
May 21, 2026
|
Full-Time
|
|
|
Associate Director, Business Development, Transactions
|
Cambridge, MA, US, 02142
|
May 15, 2026
|
Full-Time
|
|
|
Associate Director, Supply Network Strategy Operations
|
Cambridge, MA, US, 02142
|
May 21, 2026
|
Full-Time
|
|
|
Sr. Manager, Salesforce Developer
|
Cambridge, MA, US, 02142
|
May 14, 2026
|
Full-Time
|
|
|
Field Reimbursement Director - Northern California
|
Cambridge, MA, US, 02142
|
May 18, 2026
|
Full-Time
|
|
|
Business Account Executive (Chicago)
|
Cambridge, MA, US, 02142
|
Jun 1, 2026
|
Full-Time
|
|
|
Intern, HR (AI & People Analytics Focus)
|
Cambridge, MA, US, 02142
|
May 27, 2026
|
Full-Time
|
|
|
Associate Director, Marketing Technology
|
Cambridge, MA, US, 02142
|
May 31, 2026
|
Full-Time
|
|
|
Business Account Executive-Rare Disease (Dallas)
|
Cambridge, MA, US, 02142
|
May 30, 2026
|
Full-Time
|
|
|
Scientist, In Vivo Pharmacology
|
Cambridge, MA, US, 02142
|
Jun 2, 2026
|
Full-Time
|
|